245- McKenna SP. Measuring patient-reported outcomes: moving beyond misplaced common
sense to hard science. BMC Med. 2011;9:86. - Bevans M, Ross A, Cella D. Patient-reported outcomes measurement information system
(PROMIS): effi cient, standardized tools to measure self-reported health and quality of life.
Nurs Outlook. 2014;62(5):339–45. - Weldring T, Smith SM. Patient-reported outcomes (pros) and patient-reported outcome mea-
sures (proms). Health Serv Insights. 2013;6:61–8. - Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, et al. The
impact of measuring patient-reported outcomes in clinical practice: a systematic review of the
literature. Qual Life Res. 2008;17(2):179–93. - Greenhalgh J, Meadows K. The effectiveness of the use of patient-based measures of health in
routine practice in improving the process and outcomes of patient care: a literature review.
J Eval Clin Pract. 1999;5(4):401–16. - Alvarez-Hernandez E, Pelaez-Ballestas I, Vazquez-Mellado J, Teran-Estrada L, Bernard-
Medina AG, Espinoza J, et al. Validation of the health assessment questionnaire disability
index in patients with gout. Arthritis Rheum. 2008;59(5):665–9. - Spaetgens B, Tran-Duy A, Wijnands JM, van der Linden S, Boonen A. Health and utilities in
patients with gout under the care of a rheumatologist. Arthritis Care Res (Hoboken).
2015;67(8):1128–36. - ten Klooster PM, Vonkeman HE, Voshaar MA, Bode C, van de Laar MA. Experiences of gout-
related disability from the patients' perspective: a mixed methods study. Clin Rheumatol.
2014;33(8):1145–54. - Singh JA. The impact of gout on patient's lives: a study of African-American and Caucasian
men and women with gout. Arthritis Res Ther. 2014;16(3):R132. - Kim SY, Choi HK. Gout and quality of life. J Rheumatol. 2009;36(5):865–8.
- Singh JA. Quality of life and quality of care for patients with gout. Curr Rheumatol Rep.
2009;11(2):154–60. - Solomon DH, Avorn J, Levin R, Brookhart MA. Uric acid lowering therapy: prescribing pat-
terns in a large cohort of older adults. Ann Rheum Dis. 2008;67(5):609–13. - Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with
gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin
Rheumatol. 2011;17(1):1–6. - Edwards NL, Sundy JS, Forsythe A, Blume S, Pan F, Becker MA. Work productivity loss due
to fl ares in patients with chronic gout refractory to conventional therapy. J Med Econ.
2011;14(1):10–5. - Kleinman NL, Brook RA, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, et al. The impact
of gout on work absence and productivity. Value Health. 2007;10(4):231–7. - Anonymous. United states bone and joint decade: the burden of musculoskeletal diseases in
the united states. Chapter 4. Arthritis and related conditions. Rosemont: American Academy
of Orthopaedic Surgeons; 2008. - Center for Disease Control and Prevention (CDC). Gout 2015. http://www.cdc.gov/arthritis/
basics/gout.htm. - Cohen SB, Strand V, Aguilar D, Ofman JJ. Patient- versus physician-reported outcomes in
rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist
(anakinra) therapy. Rheumatology. 2004;43(6):704–11. - Lubaczewski S, Shepherd J, Fayyad R, Guico-Pabia CJ. Real-world disparities between
patient- and clinician-reported outcomes: results from a disease-specifi c program in depres-
sion and anxiety. Prof Case Manag. 2014;19(2):63–74. - Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, et al. Patient self-reports
of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst.
2011;103(24):1851–8. - Chalmers RL, Begley CG, Edrington T, Caffery B, Nelson D, Snyder C, et al. The agreement
between self-assessment and clinician assessment of dry eye severity. Cornea. 2005;24(7):804–10.
9 PROMs for Gouty Arthritis